Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Assessing antidepressant activity in rodents: recent developments and future needs.

John F Cryan1, Athina Markou, Irwin Lucki

  • 1Neuromodulation Unit, Nervous System Research, Novartis Pharma AG, WSJ 386.344, CH-4002 Basel, Switzerland. john_f.cryan@pharma.novartis.com

Trends in Pharmacological Sciences
|May 15, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Wastewater genomic surveillance of SARS-CoV-2 by nanopore sequencing uncovers JN.1 prevalence and novel spike mutational hotspots in Athens during winter 2024-2025.

The Science of the total environment·2026
Same author

Prognostic value of <i>MYD88</i>/<i>CXCR4</i> mutation allele fraction in Waldenström macroglobulinemia using a multiplex ddPCR assay.

HemaSphere·2026
Same author

Prognostic factors for cardiovascular complications induced by catecholamines in pheochromocytomas and paragangliomas: a systematic review and meta-analysis.

Hormones (Athens, Greece)·2026
Same author

ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma-cfDNA of advanced breast cancer patients: A feasibility proof-of-concept study.

Molecular oncology·2026
Same author

Cardiometabolic Burden in Bilateral Macronodular Adrenal Disease With Primary Aldosteronism.

Hypertension (Dallas, Tex. : 1979)·2026
Same author

Passive wastewater surveillance of viral pathogens on cruise ships as a powerful tool for public health protection.

Environmental pollution (Barking, Essex : 1987)·2026
Same journal

Engineering cells for solid tumor therapy.

Trends in pharmacological sciences·2026
Same journal

Targeting developmental reprogramming: hPSC insights for cancer interception.

Trends in pharmacological sciences·2026
Same journal

July 2026 issue first authors.

Trends in pharmacological sciences·2026
Same journal

Chronobiomaterials for circadian-aligned brain therapeutics.

Trends in pharmacological sciences·2026
Same journal

Biosensors for translatable GPCR bias.

Trends in pharmacological sciences·2026
Same journal

ECM stiffness and epigenetics in organ fibrosis.

Trends in pharmacological sciences·2026
See all related articles

Animal models are crucial for discovering new antidepressant medications and understanding depression. This review highlights updated models and genetic approaches for identifying novel antidepressant drug targets.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Genetics

Background:

  • Animal models are essential for antidepressant drug discovery and understanding depression's neuropathology.
  • Developing new antidepressant agents requires innovative and reliable testing paradigms.

Purpose of the Study:

  • To review recent advancements in animal models for predicting antidepressant potential.
  • To examine key issues and genetic data relevant to discovering novel antidepressant targets.

Main Methods:

  • Focus on widely employed animal models for antidepressant screening.
  • Analysis of recent modifications enhancing model utility and reliability.
  • Collating data on genetically altered mice for novel target identification.

Related Experiment Videos

Main Results:

  • Recent modifications have improved the utility and reliability of established animal models.
  • Genetically altered mice present promising avenues for novel antidepressant target discovery.
  • The review synthesizes current findings on predictive animal models for antidepressant efficacy.

Conclusions:

  • Continued refinement of animal models is vital for advancing antidepressant drug development.
  • Exploring genetically modified animal models can uncover new therapeutic targets for depression.
  • A comprehensive understanding of these models aids in the discovery of novel antidepressant agents.